Chondroitin 6-sulfotransferase (C6ST) catalyzes the transfer of sulfate to position 6 of the N-acetylgalactosamine residue of chondroitin. To obtain direct evidence regarding the function of C6ST and its product, chondroitin 6-sulfate, in vivo, we isolated the mouse C6ST gene (C6st) and generated mice deficient in this gene (C6st ؊/؊ ) by embryonic stem cell technology.
Chondroitin sulfate is a family of glycosaminoglycans (GAGs) 1 consisting of glucuronic acid (GlcA), N-acetylgalactosamine (GalNAc), and sulfate. The building block is a repeating disaccharide unit with GlcA␤1-3GalNAc, and its GalNAc residue is usually monosulfated. When sulfation occurs mainly at C-6 of the internal GalNAc residue, it is called chondroitin 6-sulfate, whereas the C-4 sulfated form is called chondroitin 4-sulfate. A variant of chondroitin 4-sulfate containing some iduronic acid residues instead of GlcA is known as dermatan sulfate, and its disaccharide unit is designated as the chondroitin sulfate B unit. Chondroitin sulfate D and E have oversulfated structures, GlcA(2S)␤1-3GalNAc(6S) and GlcA␤1-3GalNAc(4S,6S), respectively (1) . The structural diversity including various pattern of sulfate group attachment in GAGs suggests the pathological and biological importance of proteoglycan molecules (2, 3) . Chondroitin sulfate proteoglycans are the main components in the cartilage, and their sulfation profiles vary in relation to aging (4, 5) . Chondroitin sulfates in chondroitin sulfate proteoglycans have been implicated in some aspects of neuronal functions such as modulation of neurite outgrowth (6 -8) and axonal regeneration (9, 10) . Chondroitin sulfate chains also play critical roles in lymphocyte-endothelial cell interactions (11) and enhancing stimulation of T cell responses (12) . Furthermore, chondroitin sulfate proteoglycans bearing chondroitin sulfate D or E bind to a growth factor, midkine (13) (14) (15) (16) , and chemokines (17) , and have been suggested to participate in signaling or modulation of the activities of these factors. However, the in vivo function of chondroitin sulfate has not been clarified directly.
Sulfate groups attached to GAG chains are transferred from 3Ј-phosphoadenosine 5Ј-phosphosulfate (PAPS) by sulfotransferases with strict acceptor specificities (2) . Chondroitin 6-sulfotransferase (C6ST) catalyzes the last step of synthesis of chondroitin 6-sulfate, and transfers sulfate to the C-6 position of the GalNAc residue of chondroitin. Recent studies have shown that C6ST can sulfate the Gal residues of keratan sulfate (18) as well as sialyl lactosamine oligosaccharides (19) . C6ST cDNAs have been cloned in the chicken (20) and subsequently in the mouse (21) and human (22) . To determine the roles of C6ST and its product, chondroitin 6-sulfate, in vivo, we * This work was supported in part by Grants-in-aid for Scientific Research 12003898 and 12480187 from the Japan Society for the Promotion of Science and Grants-in-aid 09680616 and 10178102 for Scientific Research from the Ministry of Education, Science, Culture and Sports of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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-bis-O-sulfo-D-galactose; FACS, fluorescence-activated cell sorter; GlcA, D-glucuronic acid; PAPS, 3Ј-phosphoadenosine 5Ј-phosphosulfate;utilized gene knockout technology deleting the mouse C6ST gene, C6st. In the present study, we have shown that the number of naive T lymphocytes in the spleen of C6st Ϫ/Ϫ mice was significantly decreased.
EXPERIMENTAL PROCEDURES

Molecular Cloning of the C6st Gene and Construction of Targeting
Vector-To obtain mouse C6ST genomic DNA, a 129SV/J mouse genomic library (Stratagene) was screened using mouse C6ST cDNA (ml1; Ref. 21 ) as a probe. Plaque hybridization was carried out as described previously (21) . Two positive clones (termed 8-6 and 3-1), containing a 15-kb DNA fragment that included the C6ST coding exons, were isolated (Fig. 1A) . After sequencing the insert DNA fragments, the localization of the exons was determined by comparison of the sequences between the inserted genomic DNA and several cDNAs obtained by 5Ј-rapid amplification of cDNA ends PCR as described previously (21) and Southern blot analysis using the cDNA as a probe (21) . The C6st targeting vector was constructed from a basic targeting vector with MC1neo (polyoma virus thymidine kinase gene promoter and neomycin resistance gene) and DTA (diphtheria toxin fragment A gene) (23) and C6st fragments. To delete a 1.2-kb portion of C6st exon II (KpnI-SmaI sites in Fig. 1B) , a 4.7-kb SacI/KpnI fragment and 2.3-kb SmaI fragment were used as the 5Ј-arm and the 3Ј-arm, respectively (Fig. 1B) .
Generation of Targeted ES Cells and Mice-Aliquots of 18 g of NotI-linearized targeting vector DNA were electroporated into 1 ϫ 10 7 D3 ES cells. The cells were plated on mitomycin C-treated G418-resistant SL-10 cell feeder layers. G418 (250 g/ml; Sigma) was added 24 h after plating. G418-resistant colonies were picked up after 7-8 days and then propagated to be stored and examined for homologous recombination by Southern blot analysis as described below. Approximately 15 ES cells of the targeted clones were injected into blastocysts derived from naturally mated C57BL/6J females. The injected embryos were transferred to the uteri of pseudopregnant ICR mice. To yield null mutants of 129SV/J background, chimeric male mice were mated with 129SV/J mice. Then, F1 progeny were back-crossed four times to 129SV/J mice and mated with each other.
Southern and Northern Blot Analyses-Southern blot analysis was performed as described previously (21) for DNA samples digested with EcoRI. The membrane was hybridized with a 0.7-kb HincII-NcoI fragment corresponding to the genomic DNA downstream of the 3Ј-arm of the targeting vector (Fig. 1B) . The homologously recombined DNA gave a 7.8-kb band, whereas the wild-type DNA gave a 14.2-kb band (Fig.  1C) . Total RNA prepared from the mouse spleen was electrophoresed and transferred onto a nylon membrane, and then hybridized with the radioactive probes as described previously (21) . Hybridization was performed using a 400-bp DNA fragment corresponding to part of the C6st gene (PCR product described below) as a probe.
PCR-Aliquots of 0.5 g of DNA were mixed with 20 l of 1 ϫ AmpliTaq ® buffer containing 0.2 mM each dNTP, 1.5 mM MgCl 2 , 10 pmol of each primer, and 0.5 unit of AmpliTaq ® DNA polymerase (Applied Biosystems). PCR amplification was carried out at 94°C for 3 min, with 35 cycles of 94°C for 0.5 min, 56°C for 0.5 min, and 72°C for 1 min. To screen for homologously recombined DNA, C6st primers were used: 5Ј-ATGCATCTCTCTTGTCCCTGA-3Ј (6ST-F) and 5Ј-CACATA-CAGGTCGCATAGCAA-3Ј (6ST-R). The wild-type allele gave a 400-bp band, whereas the mutated allele gave no band. Neo primers were also used: 5Ј-CAGCGTCTTGTCATTGGCGA-3Ј (Neo-F) and 5Ј-GCTCT-TCGTCCAGATCATCC-3Ј (Neo-R). The wild-type allele gave no band, whereas the mutated allele gave a 600-bp band.
Assaying of C6ST and Chondroitin 4-Sulfotransferase (C4ST)-Mouse tissues were removed and then homogenized with a Dounce homogenizer in 1.5 ml of 0.25 M sucrose, 10 mM Tris-HCl, pH 7.2, and 0.5% Triton X-100. The homogenates were centrifuged at 10,000 ϫ g for 15 min, and the activities of C6ST and C4ST in the supernatant fractions were measured as described previously (24) with slight modifications. After the standard reaction, 35 S-labeled chondroitin substrates were purified using a Fast Desalting Column (Amersham Biosciences, Inc.) and were collected as described previously (24) . The collected 35 S-labeled products were dissolved in 50 l of a buffer containing 0.05 M Tris acetate, pH 7.5, and 10 milliunits of chondroitinase ABC (Proteus vulgaris; Seikagaku Kogyo, Tokyo, Japan). After incubation for 2 h at 37°C, the digested materials were applied to a Partisil 10-SAX column (4.6 cm ϫ 25 cm, Whatman), and fractions were collected at 30 s intervals as described previously (20) . C6ST activity and C4ST activity were determined according to the incorporation into ⌬Di-6S and ⌬Di-4S, respectively.
Extraction of Chondroitin/Dermatan Sulfates from Mouse Tissues-
Mouse spleens (1 g) and brains (4.5 g) were removed from 8 mice (5-6-week-old males) and 20 mice (over 10-week-old males), respectively. Tissues were homogenized in 10 ml of ice-cold 10 mM Tris-HCl, pH 7.5, containing 1 mM phenylmethanesulfonyl fluoride for 3 min. The homogenate was mixed with an equal volume of 10 mM Tris-HCl, pH 7.5, containing 0.5 M sucrose, 0.1 M KCl, 10 mM MgCl 2 , and 2 mM CaCl 2 , and then centrifuged at 8000 ϫ g for 10 min. The pellet was suspended in 10 ml of 10 mM Tris-HCl, pH 7.5, containing 0.1 M NaCl, 1 mM EDTA, 8 mM CHAPS, and 2.5 mg of proteinase K, and then incubated at 50°C for 4 h. After further incubation with 2.5 mg of proteinase K at 50°C for 12 h, 50 g of RNase A (Sigma) and 50 g of DNase I (Takara, Tokyo) were added, and then the reaction mixture was stored at 37°C for 1 h. The extract was centrifuged at 10,000 ϫ g for 10 min. The supernatant was applied to a column containing 4 ml of DEAE-Sephacel following by adjusting its concentration of NaCl to 0.5 M. The column was washed with five column volumes of 10 mM Tris-HCl, pH 7.5, containing 0.5 M NaCl and 8 mM CHAPS. Chondroitin/dermatan sulfate fractions were then eluted with two column volumes of 10 mM Tris-HCl, pH 7.5, containing 1.5 M NaCl and 8 mM CHAPS with monitoring at 210 nm. The collected fractions were dialyzed against distilled water.
Disaccharide Analysis on HPLC-Aliquots of 10 g of chondroitin/ dermatan sulfates extracted from the mouse spleen and brain were digested with chondroitinase ABC as described above. Samples before or after chondro-6-sulfatase (P. vulgaris; Seikagaku Kogyo) treatment (10 milliunits, at 37°C for 12 h) were then analyzed by HPLC (Partisil-10 SAX, 4.6 cm ϫ 25 cm, Whatman) as described previously (20) .
Flow Cytometric Analysis-After mincing the spleen, thymus, peripheral lymph nodes, mesenteric lymph nodes, and Peyer's patches in Hanks' balanced salt solution, single-cell suspensions were prepared in the same ice-cold solution. Cells were incubated at 4°C for 15 min in 10 g/ml Fc blocker (anti-CD32/16, 2.4G2; PharMingen) before staining with various antibodies. Cells were stained for 30 min at 4°C in Hanks' balanced salt solution containing 400-fold diluted antibody, and then washed with the same buffer. Cryostat sections (5 m thick) were fixed in acetone for 5 min and then reacted with the appropriate antibody for 1 h at room temperature. The sections were washed in phosphatebuffered saline and subsequently incubated with secondary antibody for 30 min at room temperature. After washing in phosphate-buffered saline , slides were developed with 3,3Ј-diaminobenzidine. For detection of carbohydrate epitopes, a Vectastain ® ABC kit (Vector Laboratories) was used instead of secondary antibody. The antibodies used were biotin-conjugated anti-chondroitin 6-sulfate (MC21C), anti-chondroitin sulfate D (MO-225), and anti-keratan sulfate (5D4), all from Seikagaku Kogyo. Subsequently, spleen sections were counterstained by methyl green solution. For Nissl's staining, brains were embedded in paraffin and serially sectioned in the coronal plane.
Lymphocyte Trafficking-Lymphocyte trafficking in vivo was carried out according to the published procedures with slight modifications (25, 26) . Mesenteric and axillary lymphocytes from 5-6-week-old C6st ϩ/ϩ mice were isolated and then labeled with 5 M 5-chloromethylfluorescein diacetate (CMFDA; Molecular Probes). After washing with Hanks' balanced salt solution, the cells (2.5 ϫ 10 7 in 250 l of the washing solution) were injected into the tail veins of age-matched C6st ϩ/ϩ and C6st Ϫ/Ϫ mice. After 1.5 h, the animals were sacrificed and secondary lymphoid organs were removed. CMFDA-positive lymphocytes in the organs were analyzed by flow cytometry. For detection of the trafficked cells in the spleen, the organ was immediately frozen and then cryostat sections were prepared as described above. Biotin-conjugated anti-CD3 antibody and PE-conjugated streptavidin (PharMingen) were used to detect the T cell zones.
RESULTS
Genomic Organization of the Mouse C6st
Gene-Two overlapping clones covering the mouse C6st gene were isolated by screening a 129SV/J mouse genomic library (Stratagene) using mouse C6ST cDNA as a probe. Both clones, termed clone 8-6 and 3-1 (Fig. 1A) , contained the whole protein-coding region of the C6ST cDNA, and the region appeared to be encoded by two exons divided by a 1.2-kb intron (Fig. 1A) . Exon II contained the translation initiation codon. The sequences of the intronexon splice junctions obeyed the GT-AG rule (27) . The split site of exon II and exon III was between nucleotides 375 and 376 of mouse C6ST cDNA described previously (see Fig. 1A in Ref. 21) . To determine the transcription initiation site of the gene, several cDNAs encoding 5Ј-flanking region of mouse C6st mRNAs in the spleen were isolated by 5Ј-rapid amplification of cDNA ends PCR analysis as described previously (21) and then sequenced. Sequence comparison between the cloned cDNAs and the genomic clones revealed that three unique DNA sequences, types a-c as exon I, were present in the 5Ј region upstream of C6st translation initiation codon (Fig. 1A) . Furthermore, alternative transcription initiation sites and alternative usage of exon Ia-Ic were identified (Fig. 1A) , suggesting that tissue-specific expression of the mouse C6st gene might be regulated by multiple promoters. Thus, the mouse C6st gene spans over 20 kb (Fig. 1A) .
Gene Targeting of Mouse C6st Locus-We designed a targeting construct to delete part of the catalytic region in exon III. The deletion resulted in loss of the whole 5Ј-PAPS binding domain and a portion of the 3Ј-PAPS binding domain (28) , so that any resulting translated enzyme would not have the ability to catalyze sulfation. By standard gene knockout technology, mice with deletion C6st (C6st Ϫ/Ϫ ) were produced. By mating of C6st ϩ/Ϫ mice, C6st Ϫ/Ϫ mice were born in the Mendelian ratio. There were no apparent differences between wild-type and the knockout mice in their gross morphology or results of histological examination. No significant differences were observed in body weight of C6st Ϫ/Ϫ mice as compared with C6st ϩ/ϩ mice 1, 2, 4, 6, 8, or 10 weeks after birth. The knockout mice reproduced normally and also survived for 2 years without any abnormalities as compared with wild-type controls. Southern blot analysis confirmed that the C6st gene was deleted in the knockout mice (Fig. 1C) , and no C6st mRNA was detected in these mice (Fig. 1D ). C6ST activity was not detected in the spleen, lung peripheral lymph nodes, mesenteric lymph nodes, or Peyer's patches of C6st Ϫ/Ϫ mice (Fig. 1E) . Chondroitin 4-sulfotransferase activity in such tissues was also assayed and appeared to be normal in C6st Ϫ/Ϫ mice (Fig. 1F) .
Participation of C6st in Formation of Chondroitin Sulfate
Structures-We chemically analyzed chondroitin/dermatan sulfates extracted from the spleen. After chondroitinase ABC digestion, the major disaccharide released from the sample of C6st ϩ/ϩ was ⌬Di-4S ( Fig. 2A, peak 3) . In addition, a small peak appeared at the position of ⌬Di-6S (peak 2) and ⌬Di-diS E or ⌬Di-diS B (peaks 5 and 6). Chondroitin 6-sulfatase digestion caused disappearance of ⌬Di-6S and ⌬Di-diS E peaks (Fig. 2B) . In C6st Ϫ/Ϫ mice, ⌬Di-6S level was decreased to less than 10% of that in the wild-type control (Fig. 2C) , whereas amounts of ⌬Di-4S and ⌬Di-diS E were not changed (Fig. 2D) . Thus, C6st is not involved in formation of the E unit, GlcA␤1-3GalNAc(4S,6S), in the spleen.
In chondroitin/dermatan sulfates extracted from the brain of adult mouse, the major disaccharides component was also ⌬Di-4S (Fig. 2, E-H, peak 3) . As in the case of the sample from the spleen, a small amount of ⌬Di-6S present in the sample from C6st ϩ/ϩ brain (Fig. 2E, peak 2 ) mostly disappeared in that of C6st Ϫ/Ϫ brain (Fig. 2G, peak 2) , whereas the amount of ⌬Di-diS E was not changed (Fig. 2, E and G) . Interestingly, a small amount of ⌬Di-diS D detected in the sample from C6st ϩ/ϩ mice (Fig. 2E, peak 4) was absent in the sample from C6st Ϫ/Ϫ (Fig. 2G) . Therefore, C6st is involved in formation of D unit, A) and a small amount of chondroitin 6-sulfate was present (peak 2 in A). Also, the chondroitin 4 and 6 disulfate structure was detected (peak 5 in A). In the spleen of C6st Ϫ/Ϫ mice, a very small peak of 6-sulfate was detected (peak 2 in C). In the brain of mice, the major disaccharides component was ⌬Di-4S (peak 3 in E). Small amounts of ⌬Di-6S (peak 2 in E) and ⌬Di-diS D (peak 4 in E) shown in the sample from C6st ϩ/ϩ brain were mostly disappeared in that of C6st Ϫ/Ϫ brain (peak 2 in G), whereas the amount of ⌬Di-diS E was not changed (peak 5 in G). Elution profiles around the peak positions of ⌬Di-diS D , ⌬Di-diS E , and ⌬Di-diS B are magnified as insets (E and G). Standard substances were eluted at the peak positions described below: ⌬Di-0S, peak 1; ⌬Di-6S, peak 2; ⌬Di-4S, peak 3; ⌬Di-diS D , peak 4; ⌬Di-diS E , peak 5; ⌬Di-diS B , peak 6.
(E and F) and C6st Ϫ/Ϫ mice (G and H). Chondroitinase ABC-digested (A, C, E, and G) and additional chondro 6-sulfatase-digested (B, D, F, and H) samples were subjected to HPLC. In the spleen of mice, chondroitin 4-sulfate was the main component (peak 3 in
GlcA(2S)␤1-3GalNAc(6S), in the adult brain.
Expression of chondroitin sulfate was also examined by immunohistochemical staining. When cryostat sections of the spleen were stained with MC21C antibody, which reacts with chondroitin 6-sulfate, reticular fibers and trabeculae including arteries were positive in the C6st ϩ/ϩ mice (Fig. 3A) , whereas those from C6st Ϫ/Ϫ mice were negative except in the arteries (Fig. 3B) . Cartilage tissues in C6st ϩ/ϩ day 13.5 embryos strongly expressed chondroitin sulfate D as determined by staining with MO225 antibody (Fig. 3C) . MO225-positive signals completely disappeared in the C6st Ϫ/Ϫ embryos (Fig. 3D) . Thus, C6st is also involved in formation of D unit in the embryo cartilage. C6ST also sulfates the C-6 position of Gal residues in keratan sulfate in vitro (18, 21) . 5D4 monoclonal antibody that recognizes keratan sulfate was used to evaluate whether biosynthesis of keratan sulfate in C6st Ϫ/Ϫ mice was affected. 5D4-positive signals were observed in the thalamus of C6st ϩ/ϩ day 15.5 embryos (Fig. 3E) . The intensity of 5D4-positive signals was unchanged in the thalamus of the C6st Ϫ/Ϫ embryos (Fig. 3F) . Therefore, C6st gene is not involved in synthesis of keratan sulfate in the embryonic thalamus.
Brain Development in C6st Ϫ/Ϫ Mice Was Normal-Because the chondroitin sulfate D motif, which disappeared from the brain of C6st Ϫ/Ϫ mice, was shown to promote neurite outgrowth (7), we compared brain structure between C6st ϩ/ϩ and C6st
mice by histological analysis, and found no differences. In particular, normal organization of the cerebral cortex and orientation of processes for pyramidal cells in C6st Ϫ/Ϫ brain were revealed by Nissl's staining method (Fig. 4, A-D) . Then, we investigated whether the chondroitin sulfate D structure also disappeared from the brain of the null embryos. By using MO225 monoclonal antibody, chondroitin sulfate D structure was detected in the neocortical neuroepithelium in the telencephalon of C6st ϩ/ϩ day 15.5 embryos, whereas the signals in that of C6st Ϫ/Ϫ day 15.5 embryos were not observed (Fig. 4, E  and F) .
Decrease of Naive T Lymphocytes in the Spleen of C6st
Ϫ/Ϫ
Mice-Although gross morphology of lymphoid organs was not different between C6st ϩ/ϩ mice and C6st Ϫ/Ϫ mice, the relatively strong expression of C6st mRNA in the spleen and bone marrow of mice led us to examine leukocyte populations in the spleen. We determined the numbers of free cells from the spleen, peripheral lymph nodes, mesenteric lymph nodes and Peyer's patches. The number of spleen cells in C6st Ϫ/Ϫ mice was similar to that of C6st ϩ/ϩ mice (Table I) . Then, we analyzed lymphocyte subpopulations in C6st ϩ/ϩ and C6st Ϫ/Ϫ mice. Both the percentage and number of naive T lymphocytes were significantly decreased in the spleen of C6st Ϫ/Ϫ mice at 5-6 weeks after birth (Fig. 5, Table I ). No such difference was observed in other lymphoid organs. The absolute number of naive T lymphocytes in the spleen of C6st Ϫ/Ϫ mice was ϳ68% of that in C6st ϩ/ϩ mice 5-6 weeks after birth. This result was reproducible in three independent sets of experiments. Neither chondroitin 6-sulfate nor chondroitin sulfate D was expressed on the surface of naive T lymphocytes as revealed by FACS using MC21C or MO225 antibody (data not shown). Thus, chondroitin 6-sulfate in the extracellular space (Fig. 3A) appears to be involved in the phenomenon
We investigated the reason for the decrease in number of naive T lymphocytes in the spleen of young C6st Ϫ/Ϫ mice. FACS analysis did not reveal significant differences in the populations of lymphoid cell progenitors such as Lin Ϫ IL-7R␣ ϩ c-Kitlow Sca-1 low cells (29) in bone narrow (data not shown). Moreover, differentiation and maturation of thymocytes were normal in C6st Ϫ/Ϫ mice as revealed by FACS using anti-CD4 and anti-CD8 antibodies (data not shown). Additional analyses of splenic B lymphocytes in C6st Ϫ/Ϫ mice indicated normal cell-surface expression of CD21, CD22, CD23, CD24, CD44, I-A b , IgM, IgD, and B220 (data not shown). With regard to the function of splenic lymphocytes, mitogenic responses to concanavalin A (for T cell response) and lipopolysaccharides (for B cell response) were not different between C6st ϩ/ϩ and C6st
(data not shown). 
Lymphocyte Trafficking and Morphology of the Spleen in the C6st
Ϫ/Ϫ Mice Were Normal-Because we could not exclude the possibility that the decrease of naive T lymphocytes in the spleen of C6st Ϫ/Ϫ mice was caused by the abnormal recruitment of cells to the spleen, a lymphocyte homing study was performed as described under "Experimental Procedures." Lymphocyte trafficking of extrinsic labeled lymphocytes into secondary lymph nodes of C6st Ϫ/Ϫ mice was unaltered (Fig.  6A) . Recruited cells were normally localized in the T cell area of the spleen of C6st Ϫ/Ϫ mice (Fig. 6B) . The general architecture of the C6st Ϫ/Ϫ spleen was intact as revealed by hematoxylin and eosin staining (Fig. 6, C and D) . Immunohistochemical analyses of spleen sections using anti-CD3, anti-B220, and anti-CD11c showed an overall normal architecture with a well organized T cell zone (Fig. 6B) and B cell zone (Fig. 6, E and F) in the white pulp and marginal zone (Fig. 6, E and F 
Ϫ/Ϫ mice. These results indicated that C6st deficiency did not affect lymphocyte trafficking to secondary lymphoid organs, and the significant decrease in the number of naive T lymphocytes in the C6st Ϫ/Ϫ mice spleen might have been the result of abnormal maintenance of the cells in the spleen.
DISCUSSION
The C6st gene was knocked out in the mouse, and C6ST activity was abolished almost completely in the spleen, lung, and lymph nodes of the null mutant mice. This result indicated that the C6st gene is responsible for the synthesis of chondroitin 6-sulfate, at least in these organs. Analysis of chondroitin sulfate chains in the spleen of the knockout mice gave further insight into the biosynthesis of chondroitin sulfate in this organ. The amount of chondroitin 6-sulfate was far less than that of chondroitin 4-sulfate. As expected, the peak of ⌬Di-6S was decreased to less than 10% of the wild-type level in the spleen of the knockout mice. The significance of the trace amounts of ⌬Di-6S in the knockout mice is not clear at present, because virtually no chondroitin 6-sulfotransferase activity was detected in the spleen of the knockout mice. However, other enzyme(s) that have chondroitin 6-sulfotransferase activ- (E-H) mice. The age of the C6st ϩ/ϩ and C6st Ϫ/Ϫ mice was identical. The cells were stained with fluorescein isothiocyanate-conjugated anti-CD44, PE-conjugated anti-CD62L, and biotin-conjugated anti-CD3 antibodies followed by Cy-Chrome ® -streptavidin. Naive T lymphocytes (CD3 ϩ CD62L ϩ CD44 low ) were determined by flow cytometry. The numbers indicate the percentages of CD62L ϩ CD44 low in the total CD3 ϩ cell population. The results of one representative experiment among eight are shown.
ity, e.g. N-acetylglucosamine-6-O-sulfotransferase-4/chondroitin 6-sulfotransferase-2 (30, 31), may partially compensate for the deficiency of C6st in the spleen. Interestingly, the level of ⌬Di-diS E , which is sulfated on C-4 and C-6 positions of the GalNAc residue, did not differ between C6st ϩ/ϩ and C6st Ϫ/Ϫ . This result suggested that the 4-and 6-disulfate structure is formed by 6-sulfation of 4-sulfated GalNAc in chondroitin 4-sulfate, and that the enzyme responsible for the 6-sulfation is different from C6ST. Indeed, 6-sulfotransferase forming the chondroitin 4,6-disulfate structure has been purified from squid cartilage, and shown to be devoid of chondroitin 6-sulfotransferase activity (32) . Therefore, an enzyme similar to that in the squid appears to be also present in mammals. On the other hand, chondroitin sulfate D, which contains a different disulfated disaccharide unit, i.e. C-2 sulfated GlcA and C-6 sulfated GalNAc residue, completely disappeared in the brain of C6st Ϫ/Ϫ mice and in the telencephalon and cartilage tissues of C6st Ϫ/Ϫ embryos. Thus, C6ST is involved in synthesis of the chondroitin sulfate D structure. Furthermore, this result suggested that 6-O-sulfation of the GalNAc residue catalyzed by C6ST in vivo probably precedes the 2-O-sulfation of the GlcA residue, which is likely to be catalyzed by dermatan/ chondroitin 2-sulfotransferase that requires the sulfated structure for its action (33) .
Despite the disappearance of chondroitin sulfate D structure from the embryonic and adult brain, brain development was not impaired in C6st Ϫ/Ϫ mice. Both chondroitin sulfate D (7, 34) and E (34, 35) structures promote neurite outgrowth in vivo. It is possible that the persistence of the E structure in the deficient mice might compensate for the loss of the D structure.
T lymphocytes that have differentiated and matured in the thymus of young mice migrate to the T cell areas of secondary lymphoid organs, in which nonprimed T lymphocytes, i.e. naive T lymphocytes, encounter antigen-presenting cells followed by recirculation into the blood. Because C6ST is most prominently expressed in the spleen and bone marrow (21), we performed extensive analysis on lymphocyte subpopulations of C6st Ϫ/Ϫ mice and found that naive T lymphocytes were selectively decreased in the spleen of the knockout mice 5-6 weeks after birth. Because growth monitored by the gain of body weight was not different between C6st ϩ/ϩ and C6st Ϫ/Ϫ mice, this phenomenon is not because of retarded growth of C6st Ϫ/Ϫ mice. Most of peripheral naive T lymphocytes in young mice are composed of the cells emigrated from the thymus, and recirculated from peripheral lymphoid organs. C6st mRNA was not expressed in the thymus (21) , and the population and number of CD4 ϩ CD8 Ϫ and CD4 Ϫ CD8 ϩ cells in the thymus of 5-6-weekold C6st Ϫ/Ϫ mice were unchanged (data not shown), indicating that null mutation of C6st Ϫ/Ϫ may have not affected the differentiation, maturation, and emigration of thymocytes in C6st Ϫ/Ϫ mice. It is likely that the selective paucity of naive T lymphocytes in the spleen of C6st Ϫ/Ϫ mice was caused by the functional change in the maintenance of lymphocytes in the spleen. Because recruitment of peripheral lymphocytes to the spleen was not impaired in C6st Ϫ/Ϫ mice (Fig. 6A) , we considered that survival, retention, and/or emigration of naive T lymphocytes was affected in the spleen of these mice. Chemokines as well as the growth and survival factor midkine have strong affinity for a subpopulation of chondroitin sulfate (13, showing normal lymphocytic follicles. The splenic sections were immunostained with PE-conjugated anti-B220 (red) and biotin-conjugated anti-CD11c followed by Cy-Chrome ® -streptavidin (blue), indicating that the histological architecture in the C6st Ϫ/Ϫ spleen was intact (F). B220 and CD11c are markers for B lineage and dendritic cells, respectively. 17). Furthermore, a genetic defect in the expression of secondary lymphoid organ chemokine leads to a decrease in number of naive T lymphocytes in the white pulp of the spleen as well as peripheral lymph nodes (36, 37) . It is possible that secondary lymphoid organ chemokine or another factor involved in survival, retention, and emigration of naive T lymphocytes binds to chondroitin 6-sulfate, and this binding plays a role in naive T lymphocytes' appropriate localization in the spleen. The decrease of naive T lymphocytes in the spleen of C6st Ϫ/Ϫ mice is expected to result in decreased immune response to bacteria and viruses in blood stream. One of the reasons of persistent existence of chondroitin 6-sulfate in the mouse might be their requirement for efficient defense to microorganisms.
